Lupin Ltd - Lupin Limited - Press Release Lupin Limited has informed the Exchange regarding a press release dated May 26, 2025, titled 'Lupin Announces Presentation of Phase 1 Data on LNP7457 (PRMT5 inhibitor) at the American Society of Clinical Oncology - Annual Meeting 2025'.

Lupin Ltd - Lupin Limited - Press Release

Lupin Limited has informed the Exchange regarding a press release dated May 26, 2025, titled 'Lupin Announces Presentation of Phase 1 Data on LNP7457 (PRMT5 inhibitor) at the American Society of Clinical Oncology - Annual Meeting 2025'.